Thrombospondin-1 is an
extracellular matrix protein that inhibits endothelial cell proliferation, migration, and angiogenesis. This study was performed to investigate the role of thrombospondin-1 in ischemic
retinal neovascularization. In a murine model of
retinal neovascularization, thrombospondin-1
mRNA was increased from postnatal day 13 (P13), with a threefold peak response observed on P15, corresponding to the time of development of
retinal neovascularization. Prominent expression of thrombospondin-1 was observed in neovascular cells, specifically, cells adjacent to the area of nonperfusion. It has been suggested that
vascular endothelial growth factor (
VEGF) plays a major role in
ischemia-induced
retinal neovascularization of this model, so we studied the effects of
VEGF on thrombospondin-1 expression. In bovine
retinal microcapillary endothelial cells,
VEGF induced a biphasic response of thrombospondin-1 expression;
VEGF decreased thrombospondin-1
mRNA 0.41-fold after 4 hours, whereas it increased, with a threefold peak response, after 24 hours.
VEGF-induced endothelial cell proliferation was completely inhibited by exogenous thrombospondin-1 and increased by 37.5% with anti-thrombospondin-1 antibody. The present findings suggest that, in the ischemic retina,
retinal neovascular cells increase thrombospondin-1 expression, and
VEGF may stimulate endogenous thrombospondin-1 induction, which inhibits endothelial cell growth.
VEGF-mediated thrombospondin-1 induction in
ischemia-induced angiogenesis may be a negative feedback mechanism.